These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 37125773)

  • 1. Sel1-like proteins and peptides are the major
    Arvans D; Chang C; Alshaikh A; Tesar C; Babnigg G; Wolfgeher D; Kron S; Antonopoulos D; Bashir M; Cham C; Musch M; Chang E; Joachimiak A; Hassan H
    Am J Physiol Cell Physiol; 2023 Jul; 325(1):C344-C361. PubMed ID: 37125773
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Arvans D; Jung YC; Antonopoulos D; Koval J; Granja I; Bashir M; Karrar E; Roy-Chowdhury J; Musch M; Asplin J; Chang E; Hassan H
    J Am Soc Nephrol; 2017 Mar; 28(3):876-887. PubMed ID: 27738124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the PKA signaling pathway stimulates oxalate transport by human intestinal Caco2-BBE cells.
    Arvans D; Alshaikh A; Bashir M; Weber C; Hassan H
    Am J Physiol Cell Physiol; 2020 Feb; 318(2):C372-C379. PubMed ID: 31825656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut-kidney axis in oxalate homeostasis.
    Alshaikh AE; Hassan HA
    Curr Opin Nephrol Hypertens; 2021 Mar; 30(2):264-274. PubMed ID: 33427760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter.
    Hatch M; Gjymishka A; Salido EC; Allison MJ; Freel RW
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G461-9. PubMed ID: 21163900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
    BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxalobacter formigenes treatment confers protective effects in a rat model of primary hyperoxaluria by preventing renal calcium oxalate deposition.
    Verhulst A; Dehmel B; Lindner E; Akerman ME; D'Haese PC
    Urolithiasis; 2022 Apr; 50(2):119-130. PubMed ID: 35122487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria.
    Canales BK; Hatch M
    Surg Obes Relat Dis; 2017 Jul; 13(7):1152-1157. PubMed ID: 28552742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxalobacter formigenes produces metabolites and lipids undetectable in oxalotrophic Bifidobacterium animalis.
    Chamberlain CA; Hatch M; Garrett TJ
    Metabolomics; 2020 Nov; 16(12):122. PubMed ID: 33219444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxalobacter formigenes treatment combined with intensive dialysis lowers plasma oxalate and halts disease progression in a patient with severe infantile oxalosis.
    Pape L; Ahlenstiel-Grunow T; Birtel J; Krohne TU; Hoppe B
    Pediatr Nephrol; 2020 Jun; 35(6):1121-1124. PubMed ID: 32107618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA; Sidhu H; Kaul P; Low RK
    J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.
    Ariceta G; Collard L; Abroug S; Moochhala SH; Gould E; Boussetta A; Ben Hmida M; De S; Hunley TE; Jarraya F; Fraga G; Banos A; Lindner E; Dehmel B; Schalk G
    Pediatr Nephrol; 2023 Feb; 38(2):403-415. PubMed ID: 35552824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxalobacter formigenes and its potential role in human health.
    Duncan SH; Richardson AJ; Kaul P; Holmes RP; Allison MJ; Stewart CS
    Appl Environ Microbiol; 2002 Aug; 68(8):3841-7. PubMed ID: 12147479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
    BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
    Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion.
    Hatch M; Cornelius J; Allison M; Sidhu H; Peck A; Freel RW
    Kidney Int; 2006 Feb; 69(4):691-8. PubMed ID: 16518326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomic and lipidomic characterization of Oxalobacter formigenes strains HC1 and OxWR by UHPLC-HRMS.
    Chamberlain CA; Hatch M; Garrett TJ
    Anal Bioanal Chem; 2019 Jul; 411(19):4807-4818. PubMed ID: 30740635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of enteric oxalate secretion by Oxalobacter formigenes in mice does not require the presence of either apical oxalate transport proteins Slc26A3 or Slc26A6.
    Hatch M
    Urolithiasis; 2020 Feb; 48(1):1-8. PubMed ID: 31201468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist.
    Daniel SL; Moradi L; Paiste H; Wood KD; Assimos DG; Holmes RP; Nazzal L; Hatch M; Knight J
    Appl Environ Microbiol; 2021 Aug; 87(18):e0054421. PubMed ID: 34190610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis.
    Hoppe B; Dittlich K; Fehrenbach H; Plum G; Beck BB
    Am J Kidney Dis; 2011 Sep; 58(3):453-5. PubMed ID: 21705122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.